Cargando…
A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer’s and related dementias
Among patients with Alzheimer’s disease and its related dementias (ADRD) with behavioral disturbances, antipsychotic prescriptions have limited efficacy and increase the risk of death. Yet, physicians continue to routinely prescribe low-value antipsychotic medications for behavioral disturbances amo...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767350/ https://www.ncbi.nlm.nih.gov/pubmed/36538552 http://dx.doi.org/10.1371/journal.pone.0277409 |
_version_ | 1784853947359428608 |
---|---|
author | Mafi, John N. Walling, Anne M. Villaflores, Chad Vangala, Sitaram Sorensen, Andrea Cheng, Eric Turner, Ashley Trutner, Zoe Cheng, Grace Arbanas, Julia Cave Waterman, Benjamin Shu, Suzanne Goldstein, Noah Sarkisian, Catherine |
author_facet | Mafi, John N. Walling, Anne M. Villaflores, Chad Vangala, Sitaram Sorensen, Andrea Cheng, Eric Turner, Ashley Trutner, Zoe Cheng, Grace Arbanas, Julia Cave Waterman, Benjamin Shu, Suzanne Goldstein, Noah Sarkisian, Catherine |
author_sort | Mafi, John N. |
collection | PubMed |
description | Among patients with Alzheimer’s disease and its related dementias (ADRD) with behavioral disturbances, antipsychotic prescriptions have limited efficacy and increase the risk of death. Yet, physicians continue to routinely prescribe low-value antipsychotic medications for behavioral disturbances among patients with ADRD. We designed a pragmatic randomized-controlled trial to measure the impact of a behavioral economic electronic health record (EHR) clinical decision support (CDS) intervention to reduce physician prescriptions of new antipsychotic medications among patients with ADRD. Utilizing a pragmatic parallel arm randomized-controlled trial design, the study will randomize eligible physicians from a large academic health system to either receive a EHR CDS intervention or not (control) when they prescribe a new antipsychotic medication during visits with patients with ADRD. The intervention will include three components: 1) alerts prescribers that antipsychotic prescriptions increase mortality risk (motivating physicians’ intrinsic desire for non-malfeasance); 2) offers non-pharmacological behavioral resources for caregivers; 3) auto-defaults the prescription to contain the lowest dose and number of pill-days (n = 30) without refills if the prescriber does not cancel the order (appealing to default bias). Over 1 year, we will compare the cumulative total of new antipsychotic pill-days prescribed (primary outcome) by physicians in the intervention group versus in the control group. The study protocol meets international SPIRIT guidelines. Behavioral economics, or the study of human behavior as a function of more than rational incentives, considering a whole host of cognitive and social psychological preferences, tendencies, and biases, is increasingly recognized as an important conceptual framework to improve physician behavior. This pragmatic trial is among the first to combine two distinct behavioral economic principles, a desire for non-malfeasance and default bias, to improve physician prescribing patterns for patients with ADRD. We anticipate this trial will substantially advance understanding of how behavioral-economic informed EHR CDS tools can potentially reduce harmful, low-value care among patients with ADRD. |
format | Online Article Text |
id | pubmed-9767350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-97673502022-12-21 A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer’s and related dementias Mafi, John N. Walling, Anne M. Villaflores, Chad Vangala, Sitaram Sorensen, Andrea Cheng, Eric Turner, Ashley Trutner, Zoe Cheng, Grace Arbanas, Julia Cave Waterman, Benjamin Shu, Suzanne Goldstein, Noah Sarkisian, Catherine PLoS One Study Protocol Among patients with Alzheimer’s disease and its related dementias (ADRD) with behavioral disturbances, antipsychotic prescriptions have limited efficacy and increase the risk of death. Yet, physicians continue to routinely prescribe low-value antipsychotic medications for behavioral disturbances among patients with ADRD. We designed a pragmatic randomized-controlled trial to measure the impact of a behavioral economic electronic health record (EHR) clinical decision support (CDS) intervention to reduce physician prescriptions of new antipsychotic medications among patients with ADRD. Utilizing a pragmatic parallel arm randomized-controlled trial design, the study will randomize eligible physicians from a large academic health system to either receive a EHR CDS intervention or not (control) when they prescribe a new antipsychotic medication during visits with patients with ADRD. The intervention will include three components: 1) alerts prescribers that antipsychotic prescriptions increase mortality risk (motivating physicians’ intrinsic desire for non-malfeasance); 2) offers non-pharmacological behavioral resources for caregivers; 3) auto-defaults the prescription to contain the lowest dose and number of pill-days (n = 30) without refills if the prescriber does not cancel the order (appealing to default bias). Over 1 year, we will compare the cumulative total of new antipsychotic pill-days prescribed (primary outcome) by physicians in the intervention group versus in the control group. The study protocol meets international SPIRIT guidelines. Behavioral economics, or the study of human behavior as a function of more than rational incentives, considering a whole host of cognitive and social psychological preferences, tendencies, and biases, is increasingly recognized as an important conceptual framework to improve physician behavior. This pragmatic trial is among the first to combine two distinct behavioral economic principles, a desire for non-malfeasance and default bias, to improve physician prescribing patterns for patients with ADRD. We anticipate this trial will substantially advance understanding of how behavioral-economic informed EHR CDS tools can potentially reduce harmful, low-value care among patients with ADRD. Public Library of Science 2022-12-20 /pmc/articles/PMC9767350/ /pubmed/36538552 http://dx.doi.org/10.1371/journal.pone.0277409 Text en © 2022 Mafi et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Study Protocol Mafi, John N. Walling, Anne M. Villaflores, Chad Vangala, Sitaram Sorensen, Andrea Cheng, Eric Turner, Ashley Trutner, Zoe Cheng, Grace Arbanas, Julia Cave Waterman, Benjamin Shu, Suzanne Goldstein, Noah Sarkisian, Catherine A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer’s and related dementias |
title | A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer’s and related dementias |
title_full | A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer’s and related dementias |
title_fullStr | A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer’s and related dementias |
title_full_unstemmed | A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer’s and related dementias |
title_short | A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer’s and related dementias |
title_sort | pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with alzheimer’s and related dementias |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767350/ https://www.ncbi.nlm.nih.gov/pubmed/36538552 http://dx.doi.org/10.1371/journal.pone.0277409 |
work_keys_str_mv | AT mafijohnn apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT wallingannem apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT villafloreschad apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT vangalasitaram apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT sorensenandrea apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT chengeric apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT turnerashley apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT trutnerzoe apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT chenggrace apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT arbanasjuliacave apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT watermanbenjamin apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT shusuzanne apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT goldsteinnoah apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT sarkisiancatherine apragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT mafijohnn pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT wallingannem pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT villafloreschad pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT vangalasitaram pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT sorensenandrea pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT chengeric pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT turnerashley pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT trutnerzoe pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT chenggrace pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT arbanasjuliacave pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT watermanbenjamin pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT shusuzanne pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT goldsteinnoah pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias AT sarkisiancatherine pragmaticparallelarmrandomizedcontrolledtrialofamultiprongedelectronichealthrecordbasedclinicaldecisionsupporttoolprotocoltoreducelowvalueantipsychoticprescriptionsamongolderadultswithalzheimersandrelateddementias |